Frontlight ResearchEarly access
Diabetic eye disease trials in Japan
3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2CompletedA Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
- Where
- Akita, Amagasaki-shi, Fukuoka, Fukushima, Hachioji-shi, Kagawa, Kita-gun, Kagoshima, Kashihara, Kobe, Matsumoto-shi, Meguro-Ku, Nagakute, Nishinomiya, Tokyo
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06321302 · EU 2023-508891-12-00 - Phase 2Taking peopleA Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Where
- Asahikawa-Shi, Chofu-shi, Hachioji-shi, Kita-gun, Kurume-shi, Matsumoto-shi, Meguro-Ku, Nagayoga, Osaka, tabashi City, Tokyo, Urayasu-shi
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06962839 · EU 2024-520384-14-00 - Phase 3Not yet taking people in JapanA Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
- Where
- Amagasaki-shi, Fukuoka, Fukushima, Hachioji-shi, Kagoshima, Kita-gun, Kobe, Kyoto, Mitaka-shi, Mito, Miyazaki, Nagoya, Sakura-shi, Tokyo
- Age
- 18 years and over
- People
- 514 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07867080